Surmodics Inc., a prominent player in the health care equipment and supplies sector, has been making significant strides in the medical device industry. Based in Eden Prairie, United States, the company specializes in the design and manufacturing of a range of medical devices. These include coronary stent systems, angioplasty catheters, chronic total occlusion devices, specialty guide wires, and intravascular sensors. Surmodics has carved a niche for itself by focusing exclusively on the U.S. market, offering its innovative products through its online platform at www.surmodics.com .
As of November 6, 2025, Surmodics Inc.’s stock was trading at a close price of $26.79 on the Nasdaq, where it is publicly listed. The company’s market capitalization stands at approximately $383 million USD, reflecting its position within the industry. Over the past year, the stock has experienced fluctuations, reaching a 52-week high of $40.39 on December 10, 2024, and a low of $25.87 on November 4, 2025.
Despite its innovative product offerings and market presence, Surmodics Inc. has faced financial challenges, as indicated by its price-to-earnings ratio of -21.61. This negative ratio suggests that the company is currently not generating profits, which may be a point of concern for investors. However, the company’s focus on specialized medical devices and its established market presence in the United States continue to be significant factors in its operational strategy.
Surmodics Inc. was established as a public company following its initial public offering on March 4, 1998. Since then, it has maintained a steady course in the health care equipment and supplies industry, leveraging its expertise in medical device manufacturing to meet the needs of healthcare providers and patients.
As the company navigates the complexities of the health care market, its commitment to innovation and quality remains central to its business model. Surmodics Inc. continues to invest in research and development to enhance its product offerings and maintain its competitive edge in the industry.
